BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Hung GY, Horng JL, Yen HJ, Lee CY, Lin LY. Changing incidence patterns of hepatocellular carcinoma among age groups in Taiwan. J Hepatol 2015;63:1390-6. [PMID: 26256438 DOI: 10.1016/j.jhep.2015.07.032] [Cited by in Crossref: 56] [Cited by in F6Publishing: 51] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Cheng S, Han Y, Jiang L, Lan Z, Guo J. National, regional, and global cardiomyopathy burden from 1990 to 2019. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.1042448] [Reference Citation Analysis]
2 Zhao Z, Huang G, He Y, Zuo X, Han W, Hong L. Trends of uterine cancer burden in 204 countries and regions from 2000 to 2019 and disease burden prediction.. [DOI: 10.21203/rs.3.rs-2251857/v1] [Reference Citation Analysis]
3 Li Y, Ou Z, Yu D, He H, Zheng L, Chen J, Chen C, Xiong H, Chen Q. The trends in death of primary liver cancer caused by specific etiologies worldwide: results from the Global Burden of Disease Study 2019 and implications for liver cancer management.. [DOI: 10.21203/rs.3.rs-2200639/v1] [Reference Citation Analysis]
4 Cheng L, Li H, Gong Q, Huang C, Zhang C, Yan J. Global, regional, and national burden of uterine fibroids in the last 30 years: Estimates from the 1990 to 2019 Global Burden of Disease Study. Front Med 2022;9. [DOI: 10.3389/fmed.2022.1003605] [Reference Citation Analysis]
5 Xu S, Chen Y, Lin R, Huang W, Zhou H, Lin Y, Xu M. Burden of atrial fibrillation and its attributable risk factors from 1990 to 2019: An analysis of the Global Burden of Disease study 2019. Front Cardiovasc Med 2022;9. [DOI: 10.3389/fcvm.2022.997698] [Reference Citation Analysis]
6 Wang B, Chen Y, Zhu X, Wang T, Li M, Huang Y, Xue L, Zhu Q, Gao X, Wu M. Global burden and trends of pelvic organ prolapse associated with aging women: An observational trend study from 1990 to 2019. Front Public Health 2022;10:975829. [DOI: 10.3389/fpubh.2022.975829] [Reference Citation Analysis]
7 Zhang X, Wang X, Wang M, Hu B, Tang W, Wu Y, Gu J, Ni T, Li Q. The global burden of type 2 diabetes attributable to high body mass index in 204 countries and territories, 1990–2019: An analysis of the Global Burden of Disease Study. Front Public Health 2022;10:966093. [DOI: 10.3389/fpubh.2022.966093] [Reference Citation Analysis]
8 Ye F, Zhai M, Long J, Gong Y, Ren C, Zhang D, Lin X, Liu S. The burden of liver cirrhosis in mortality: Results from the global burden of disease study. Front Public Health 2022;10:909455. [DOI: 10.3389/fpubh.2022.909455] [Reference Citation Analysis]
9 Safcak D, Drazilova S, Gazda J, Andrasina I, Adamcova-selcanova S, Balazova L, Barila R, Mego M, Rac M, Skladany L, Zigrai M, Janicko M, Jarcuska P. Inflammatory Indexes as Prognostic Factors of Survival in Geriatric Patients with Hepatocellular Carcinoma: A Case Control Study of Eight Slovak Centers. JCM 2022;11:4183. [DOI: 10.3390/jcm11144183] [Reference Citation Analysis]
10 Flores JE, Thompson AJ, Ryan M, Howell J. The Global Impact of Hepatitis B Vaccination on Hepatocellular Carcinoma. Vaccines 2022;10:793. [DOI: 10.3390/vaccines10050793] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
11 Huang PH, Yu J, Chu YY, Lin YH, Yeh CT. Child-Pugh Score and ABCG2-rs2231142 Genotype Independently Predict Survival in Advanced Hepatoma Patients Treated with Sorafenib. J Clin Med 2022;11:2550. [PMID: 35566676 DOI: 10.3390/jcm11092550] [Reference Citation Analysis]
12 Zhou X, Zhang F, Ao Y, Lu C, Li T, Xu X, Zeng H. Diagnosis experiences from 50 hepatitis B patients in Chongqing, China: a qualitative study. BMC Public Health 2021;21:2195. [PMID: 34852813 DOI: 10.1186/s12889-021-11929-9] [Reference Citation Analysis]
13 Long J, Sun Y, Zhao J, Liu J, Peng X. Temporal trends of carbon monoxide poisoning mortality at the global, regional and national levels: a cross-sectional study from the Global Burden of Disease study, 1990 and 2017. BMJ Open 2021;11:e053240. [PMID: 34789496 DOI: 10.1136/bmjopen-2021-053240] [Reference Citation Analysis]
14 Macias RIR, Monte MJ, Serrano MA, González-Santiago JM, Martín-Arribas I, Simão AL, Castro RE, González-Gallego J, Mauriz JL, Marin JJG. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics. Aging (Albany NY) 2021;13:23416-34. [PMID: 34633987 DOI: 10.18632/aging.203620] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
15 Wang W, Hu M, Liu H, Zhang X, Li H, Zhou F, Liu YM, Lei F, Qin JJ, Zhao YC, Chen Z, Liu W, Song X, Huang X, Zhu L, Ji YX, Zhang P, Zhang XJ, She ZG, Yang J, Yang H, Cai J, Li H. Global Burden of Disease Study 2019 suggests that metabolic risk factors are the leading drivers of the burden of ischemic heart disease. Cell Metab 2021;33:1943-1956.e2. [PMID: 34478633 DOI: 10.1016/j.cmet.2021.08.005] [Cited by in Crossref: 14] [Cited by in F6Publishing: 12] [Article Influence: 14.0] [Reference Citation Analysis]
16 Alqahtani SA, Schattenberg JM. NAFLD in the Elderly. Clin Interv Aging 2021;16:1633-49. [PMID: 34548787 DOI: 10.2147/CIA.S295524] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
17 Chon YE, Jeong SW, Jun DW. Hepatocellular carcinoma statistics in South Korea. Clin Mol Hepatol 2021;27:512-4. [PMID: 34153973 DOI: 10.3350/cmh.2021.0171] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
18 Zhang Y, Yang C, Huang M. Global, regional, and national burden of biliary tract cancer from 1990 to 2017 based on the 2017 Global Burden of Disease study. Cancer Epidemiol 2021;73:101949. [PMID: 33992881 DOI: 10.1016/j.canep.2021.101949] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
19 Zhai M, Liu Z, Long J, Zhou Q, Yang L, Zhou Q, Liu S, Dai Y. The incidence trends of liver cirrhosis caused by nonalcoholic steatohepatitis via the GBD study 2017. Sci Rep 2021;11:5195. [PMID: 33664363 DOI: 10.1038/s41598-021-84577-z] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 8.0] [Reference Citation Analysis]
20 Rigopoulou EI, Dalekos GN. Current Trends and Characteristics of Hepatocellular Carcinoma in Patients with Autoimmune Liver Diseases. Cancers (Basel) 2021;13:1023. [PMID: 33804480 DOI: 10.3390/cancers13051023] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
21 Zhai M, Long J, Liu S, Liu C, Li L, Yang L, Li Y, Shu B. The burden of liver cirrhosis and underlying etiologies: results from the global burden of disease study 2017. Aging (Albany NY) 2021;13:279-300. [PMID: 33436531 DOI: 10.18632/aging.104127] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
22 Sharma R. Descriptive epidemiology of incidence and mortality of primary liver cancer in 185 countries: evidence from GLOBOCAN 2018. Jpn J Clin Oncol 2020;50:1370-9. [PMID: 32719873 DOI: 10.1093/jjco/hyaa130] [Cited by in Crossref: 30] [Cited by in F6Publishing: 31] [Article Influence: 30.0] [Reference Citation Analysis]
23 Liu J, Ren ZH, Qiang H, Wu J, Shen M, Zhang L, Lyu J. Trends in the incidence of diabetes mellitus: results from the Global Burden of Disease Study 2017 and implications for diabetes mellitus prevention. BMC Public Health 2020;20:1415. [PMID: 32943028 DOI: 10.1186/s12889-020-09502-x] [Cited by in Crossref: 63] [Cited by in F6Publishing: 67] [Article Influence: 31.5] [Reference Citation Analysis]
24 Fan J, Liu Z, Mao X, Tong X, Zhang T, Suo C, Chen X. Global trends in the incidence and mortality of esophageal cancer from 1990 to 2017. Cancer Med 2020;9:6875-87. [PMID: 32750217 DOI: 10.1002/cam4.3338] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 15.5] [Reference Citation Analysis]
25 Wang XY, Huang JM, Lu XM, Harrison TJ, Liu HB, Jia HH, Fang ZL. Changing risk factors for hepatocellular carcinoma in hyperendemic regions in the era of universal hepatitis B vaccination. Cancer Epidemiol 2020;67:101775. [PMID: 32623359 DOI: 10.1016/j.canep.2020.101775] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
26 Lin CL, Kao JH. Hepatitis B: Immunization and Impact on Natural History and Cancer Incidence. Gastroenterol Clin North Am 2020;49:201-14. [PMID: 32389359 DOI: 10.1016/j.gtc.2020.01.010] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
27 Chaudhuri D, Datta J, Majumder S, Giri K. In silico designing of peptide based vaccine for Hepatitis viruses using reverse vaccinology approach. Infect Genet Evol 2020;84:104388. [PMID: 32485330 DOI: 10.1016/j.meegid.2020.104388] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
28 Tachi K, Agyei-Nkansah A, Archampong T. Hepatocellular carcinoma in Ghana: a retrospective analysis of a tertiary hospital data. Pan Afr Med J 2020;36:43. [PMID: 32774619 DOI: 10.11604/pamj.2020.36.43.21085] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
29 Moyad MA. Preventing Lethal Prostate Cancer with Diet, Supplements, and Rx: Heart Healthy Continues to Be Prostate Healthy and "First Do No Harm" Part III. Curr Urol Rep 2020;21:22. [PMID: 32367257 DOI: 10.1007/s11934-020-00972-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
30 Dasgupta P, Henshaw C, Youlden DR, Aitken JF, Sullivan A, Irving H, Baade PD. Global trends in incidence rates of childhood liver cancers: A systematic review and meta‐analysis. Paediatr Perinat Epidemiol 2020;34:609-17. [DOI: 10.1111/ppe.12671] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
31 Dasgupta P, Henshaw C, Youlden DR, Clark PJ, Aitken JF, Baade PD. Global Trends in Incidence Rates of Primary Adult Liver Cancers: A Systematic Review and Meta-Analysis. Front Oncol 2020;10:171. [PMID: 32185125 DOI: 10.3389/fonc.2020.00171] [Cited by in Crossref: 76] [Cited by in F6Publishing: 79] [Article Influence: 38.0] [Reference Citation Analysis]
32 Basen-engquist K, Brown P, Coletta AM, Savage M, Maresso KC, Hawk E. Lifestyle and Cancer Prevention. Abeloff's Clinical Oncology 2020. [DOI: 10.1016/b978-0-323-47674-4.00022-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
33 Zhu YF, Tan YF, Xu X, Zheng JL, Zhang BH, Tang HR, Yang JY. Gamma-glutamyl transpeptidase-to-platelet ratio and the fibrosis-4 index in predicting hepatitis B virus-related hepatocellular carcinoma development in elderly chronic hepatitis B patients in China: A single-center retrospective study. Medicine (Baltimore) 2019;98:e18319. [PMID: 31852119 DOI: 10.1097/MD.0000000000018319] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
34 Li N, Deng Y, Zhou L, Tian T, Yang S, Wu Y, Zheng Y, Zhai Z, Hao Q, Song D, Zhang D, Kang H, Dai Z. Global burden of breast cancer and attributable risk factors in 195 countries and territories, from 1990 to 2017: results from the Global Burden of Disease Study 2017. J Hematol Oncol 2019;12:140. [PMID: 31864424 DOI: 10.1186/s13045-019-0828-0] [Cited by in Crossref: 139] [Cited by in F6Publishing: 151] [Article Influence: 46.3] [Reference Citation Analysis]
35 Atyah M, Yin YR, Zhou CH, Zhou Q, Chen WY, Dong QZ, Ren N. Integrated analysis of the impact of age on genetic and clinical aspects of hepatocellular carcinoma. Aging (Albany NY) 2018;10:2079-97. [PMID: 30125264 DOI: 10.18632/aging.101531] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
36 Liu Z, Jiang Y, Yuan H, Fang Q, Cai N, Suo C, Jin L, Zhang T, Chen X. The trends in incidence of primary liver cancer caused by specific etiologies: Results from the Global Burden of Disease Study 2016 and implications for liver cancer prevention. J Hepatol 2019;70:674-83. [PMID: 30543829 DOI: 10.1016/j.jhep.2018.12.001] [Cited by in Crossref: 248] [Cited by in F6Publishing: 247] [Article Influence: 82.7] [Reference Citation Analysis]
37 Chen VC, Lin CF, Hsieh YH, Liang HY, Huang KY, Chiu WC, Lee Y, McIntyre RS, Chan HL. Hepatocellular carcinoma and antidepressants: a nationwide population-based study. Oncotarget 2017;8:30464-70. [PMID: 27783998 DOI: 10.18632/oncotarget.12826] [Cited by in Crossref: 16] [Cited by in F6Publishing: 18] [Article Influence: 4.0] [Reference Citation Analysis]
38 Najar RA, Wani NA, Bhat JA, Dar NJ, Rahat B, Gupta AP, Kaur J, Kaur J, Hamid A. Modulation of dietary folate with age confers selective hepatocellular epigenetic imprints through DNA methylation. The Journal of Nutritional Biochemistry 2018;53:121-32. [DOI: 10.1016/j.jnutbio.2017.10.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
39 Wiktor SZ. Viral Hepatitis. In: Holmes KK, Bertozzi S, Bloom BR, Jha P, editors. Disease Control Priorities, Third Edition (Volume 6): Major Infectious Diseases. The World Bank; 2017. pp. 401-9. [DOI: 10.1596/978-1-4648-0524-0_ch16] [Cited by in Crossref: 1] [Article Influence: 0.2] [Reference Citation Analysis]
40 Surveillance group. ; Diagnosis group; Staging group; Surgery group; Local ablation group; TACE/TARE/HAI group; Target therapy/systemic therapy group; Radiotherapy group; Prevention group; Drafting group. Management consensus guideline for hepatocellular carcinoma: 2016 updated by the Taiwan Liver Cancer Association and the Gastroenterological Society of Taiwan. J Formos Med Assoc. 2018;117:381-403. [PMID: 29074347 DOI: 10.1016/j.jfma.2017.09.007] [Cited by in Crossref: 66] [Cited by in F6Publishing: 73] [Article Influence: 13.2] [Reference Citation Analysis]
41 Goh GB, Li JW, Chang PE, Chow KY, Tan CK. Deciphering the epidemiology of hepatocellular carcinoma through the passage of time: A study of 1,401 patients across 3 decades. Hepatol Commun 2017;1:564-71. [PMID: 29404479 DOI: 10.1002/hep4.1059] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
42 Wang J, Mao Y, Liu Y, Chen Z, Chen M, Lao X, Li S. Hepatocellular Carcinoma in Children and Adolescents: Clinical Characteristics and Treatment. J Gastrointest Surg 2017;21:1128-35. [PMID: 28397025 DOI: 10.1007/s11605-017-3420-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.4] [Reference Citation Analysis]
43 Aronson DC, Meyers RL. Malignant tumors of the liver in children. Semin Pediatr Surg 2016;25:265-75. [PMID: 27955729 DOI: 10.1053/j.sempedsurg.2016.09.002] [Cited by in Crossref: 76] [Cited by in F6Publishing: 78] [Article Influence: 12.7] [Reference Citation Analysis]
44 Plummer M, de Martel C, Vignat J, Ferlay J, Bray F, Franceschi S. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016;4:e609-e616. [PMID: 27470177 DOI: 10.1016/s2214-109x(16)30143-7] [Cited by in Crossref: 851] [Cited by in F6Publishing: 901] [Article Influence: 141.8] [Reference Citation Analysis]
45 Yeesoonsang S, Bilheem S, McNeil E, Iamsirithaworn S, Jiraphongsa C, Sriplung H. Estimation of the Incidence of Hepatocellular Carcinoma and Cholangiocarcinoma in Songkhla, Thailand, 1989-2013, Using Multiple Imputation Method. Cancer Res Treat 2017;49:54-60. [PMID: 27188200 DOI: 10.4143/crt.2016.045] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
46 Hung GY, Chen CC, Horng JL, Lin LY. Cancer in adolescents: Incidences and trends during 1995-2009 in Taiwan. Cancer Lett 2016;372:110-7. [PMID: 26742461 DOI: 10.1016/j.canlet.2015.12.030] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
47 Leroy V, Asselah T. Universal hepatitis B vaccination: The only way to eliminate hepatocellular carcinoma? J Hepatol 2015;63:1303-5. [PMID: 26450812 DOI: 10.1016/j.jhep.2015.10.001] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]